Wealth Enhancement Advisory Services
GOSS icon

Wealth Enhancement Advisory Services’s Gossamer Bio GOSS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
1,924
+631
+49% +$14.1K ﹤0.01% 4025
2026
Q1 		$29.1K Buy
1,293
+993
+331% +$125K ﹤0.01% 3476
2025
Q4 		$59.3K Buy
300
+60
+25% +$13.7K ﹤0.01% 3522
2025
Q3 		$48K Buy
+240
New +$42.3K ﹤0.01% 3436

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Wealth Enhancement Advisory Services's GOSS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Gossamer Bio (GOSS) stake by 49% in Q2 2026, buying an estimated $14.1K and bringing the position to 1,924 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #4025.

Wealth Enhancement Advisory Services first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $59.3K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 1,924 shares of Gossamer Bio worth $22K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 631 Gossamer Bio shares in Q2 2026, an estimated $14.1K.
  • Gossamer Bio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4025 holding.
  • Wealth Enhancement Advisory Services first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Gossamer Bio position peaked at $59.3K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.